Get the Stockscreener App
12.39
0.32%
0.04
After Hours:
12.47
0.08
+0.65%
Tandem Diabetes Care Inc stock is traded at $12.39, with a volume of 1.36M.
It is up +0.32% in the last 24 hours and down -19.65% over the past month.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
See More
Previous Close:
$12.35
Open:
$12.4
24h Volume:
1.36M
Relative Volume:
0.69
Market Cap:
$837.19M
Revenue:
$796.00M
Net Income/Loss:
$-136.49M
P/E Ratio:
-5.9282
EPS:
-2.09
Net Cash Flow:
$-64.24M
1W Performance:
+5.09%
1M Performance:
-19.65%
6M Performance:
-36.43%
1Y Performance:
-69.87%
1-Day Range:
$11.88
$12.50
1-Week Range:
$11.83
$13.10
52-Week Range:
$9.98
$47.60
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Name
Tandem Diabetes Care Inc
Sector
Industry
Phone
858-366-6900
Address
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
12.39 | 863.54M | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-25 | Upgrade | Citigroup | Sell → Neutral |
| Aug-07-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-09-25 | Downgrade | Citigroup | Neutral → Sell |
| Jun-16-25 | Initiated | Truist | Hold |
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Mar-05-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Mar-03-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-28-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-06-24 | Initiated | Bernstein | Outperform |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Oct-02-24 | Initiated | RBC Capital Mkts | Outperform |
| Aug-22-24 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-08-24 | Initiated | Canaccord Genuity | Buy |
| May-30-24 | Initiated | Redburn Atlantic | Buy |
| May-22-24 | Upgrade | Citigroup | Neutral → Buy |
| Apr-29-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-25-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Mar-26-24 | Upgrade | Stifel | Hold → Buy |
| Aug-04-23 | Downgrade | Citigroup | Buy → Neutral |
| May-05-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Apr-24-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-15-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Aug-09-22 | Downgrade | Wells Fargo | Overweight → Underweight |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-20-20 | Initiated | Wells Fargo | Overweight |
| Jul-31-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jul-06-20 | Upgrade | Citigroup | Neutral → Buy |
| Jun-18-20 | Reiterated | Raymond James | Outperform |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-06-20 | Initiated | Raymond James | Outperform |
| Feb-04-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-18-19 | Initiated | Guggenheim | Buy |
| Oct-04-19 | Upgrade | UBS | Neutral → Buy |
| May-17-19 | Reiterated | BofA/Merrill | Neutral |
| May-13-19 | Initiated | SVB Leerink | Outperform |
| Mar-08-19 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-27-19 | Reiterated | Lake Street | Buy |
| Nov-21-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-26-18 | Reiterated | Dougherty & Company | Buy |
| Sep-26-18 | Reiterated | Piper Jaffray | Overweight |
View All
Tandem Diabetes Care Inc Stock (TNDM) Latest News
Is Tandem Diabetes Care Inc. a strong candidate for buy and hold2025 Technical Patterns & Smart Swing Trading Alerts - khodrobank.com
Should you wait for a breakout in Tandem Diabetes Care Inc.July 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - Newser
Is now a turning point for Tandem Diabetes Care Inc.Stop Loss & High Conviction Investment Ideas - Newser
Analyzing recovery setups for Tandem Diabetes Care Inc. investorsTrade Volume Report & Weekly Setup with ROI Potential - Newser
What Fibonacci levels say about Tandem Diabetes Care Inc. reboundJuly 2025 EndofMonth & AI Powered Trade Plan Recommendations - Newser
Combining price and volume data for Tandem Diabetes Care Inc.Risk Management & Real-Time Chart Breakout Alerts - Newser
How to escape a deep drawdown in Tandem Diabetes Care Inc.2025 Stock Rankings & Long-Term Investment Growth Plans - Newser
Backtesting results for Tandem Diabetes Care Inc. trading strategiesJuly 2025 Levels & Reliable Entry Point Alerts - Newser
Using Ichimoku Cloud for Tandem Diabetes Care Inc. technicalsJuly 2025 Big Picture & Community Consensus Trade Signals - Newser
How to read the order book for Tandem Diabetes Care Inc.July 2025 Market Mood & Stepwise Swing Trade Plans - Newser
What to expect from Tandem Diabetes Care Inc. in the next 30 daysJobs Report & Precise Swing Trade Alerts - Newser
Published on: 2025-09-03 02:48:30 - Newser
How high can Tandem Diabetes Care Inc. stock go2025 Analyst Calls & Detailed Earnings Play Strategies - Newser
Sector ETF performance correlation with Tandem Diabetes Care Inc.Trade Analysis Report & Verified Chart Pattern Trade Signals - Newser
Why Tandem Diabetes Care Inc. is moving todayInsider Selling & Free Daily Entry Point Trade Alerts - Newser
What is Tandem Diabetes Care Inc.’s valuation compared to sectorWeekly Stock Summary & Precise Entry and Exit Recommendations - khodrobank.com
Long term hold vs stop loss in Tandem Diabetes Care Inc.July 2025 Short Interest & AI Driven Stock Reports - Newser
Tick level data insight on Tandem Diabetes Care Inc. volatilityTrade Exit Summary & Technical Pattern Based Buy Signals - Newser
Published on: 2025-09-02 05:08:07 - Newser
What is the earnings history of Tandem Diabetes Care Inc.2025 Volume Leaders & Growth-Oriented Investment Plans - خودرو بانک
Is Tandem Diabetes Care Inc. stock a smart retirement pick2025 Buyback Activity & Long-Term Growth Portfolio Plans - khodrobank.com
Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say - MSN
Can Tandem Diabetes Care Inc. generate free cash flowJuly 2025 Summary & Expert-Curated Trade Recommendations - خودرو بانک
Is Tandem Diabetes Care Inc. a speculative investmentMarket Volume Summary & Fast Momentum Stock Entry Tips - khodrobank.com
Investigation Underway: Tandem Diabetes Care, Inc. (TNDM)Contact Levi & Korsinsky Over Securities Law Violations - ACCESS Newswire
News impact scoring models applied to Tandem Diabetes Care Inc.July 2025 Levels & Real-Time Stock Entry Alerts - Newser
Tandem Diabetes Care Inc. stock daily chart insightsMarket Risk Analysis & Consistent Return Strategy Ideas - Newser
Applying Wyckoff theory to Tandem Diabetes Care Inc. stockTrade Analysis Report & Daily Volume Surge Signals - Newser
Published on: 2025-08-31 20:30:16 - Newser
Diabetes warning issued over insulin pump error - MSN
What makes Tandem Diabetes Care Inc. stock price move sharplyJuly 2025 Weekly Recap & Trade Opportunity Analysis - Newser
Measuring Tandem Diabetes Care Inc.’s beta against major indicesPortfolio Return Report & Free Technical Confirmation Trade Alerts - Newser
Unpacking Tandem Diabetes Care's Sharp Intraday Move - AInvest
Tandem Diabetes Care Inc. stock volume spike explained2025 Year in Review & Weekly Top Gainers Alerts - Newser
Tandem Diabetes Care (TNDM.O) Sees Sharp Intraday Move Without Clear Catalyst - AInvest
ATTENTION Tandem Diabetes Care, Inc. (TNDM) Investors: Possible FraudContact Levi & Korsinsky Today - ACCESS Newswire
Tandem Diabetes Care Surges 6.1%—Technical Signals Stay Quiet, Volume Rises - AInvest
What data driven models say about Tandem Diabetes Care Inc.’s futureOil Prices & Long-Term Growth Stock Strategies - Newser
Will Tandem Diabetes Care Inc. rebound enough to break evenWeekly Loss Report & Consistent Return Strategy Ideas - Newser
How institutional ownership impacts Tandem Diabetes Care Inc. stockQuarterly Trade Summary & Daily Entry Point Alerts - Newser
How to monitor Tandem Diabetes Care Inc. with trend dashboardsWeekly Gains Summary & Risk Adjusted Buy/Sell Alerts - Newser
Sector ETF performance correlation with Tandem Diabetes Care IncWeekly Volume Report & Weekly High Conviction Ideas - Newser
Price momentum metrics for Tandem Diabetes Care Inc. explainedJuly 2025 Pullbacks & Proven Capital Preservation Tips - Newser
Tandem Diabetes Care Inc Stock (TNDM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tandem Diabetes Care Inc Stock (TNDM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Morrison Susan | EVP & Chief Admin. Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
2,600 |
0 |
39,376 |
| Sheridan John F | PRESIDENT & CEO |
Aug 15 '25 |
Option Exercise |
0.00 |
11,453 |
0 |
115,001 |
| Carpenter Rick | Chief Technology Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
2,335 |
0 |
22,824 |
| Vosseller Leigh | EVP & CHIEF FINANCIAL OFFICER |
Aug 15 '25 |
Option Exercise |
0.00 |
2,998 |
0 |
36,258 |
| Hansen Shannon Marie | EVP & Chief Legal Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
3,065 |
0 |
19,102 |
| Gasser Elizabeth Anne | EVP, Chief Strategy Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
2,600 |
0 |
1,795 |
| Sheridan John F | PRESIDENT & CEO |
Aug 11 '25 |
Buy |
10.23 |
10,000 |
102,318 |
106,327 |
| Vosseller Leigh | EVP & CHIEF FINANCIAL OFFICER |
Aug 08 '25 |
Buy |
10.89 |
13,720 |
149,404 |
25,580 |
| Kyrillos Jean-Claude | EVP & Chief Operating Officer |
Jul 15 '25 |
Option Exercise |
0.00 |
14,545 |
0 |
25,254 |
| Carpenter Rick | Chief Technology Officer |
Jun 16 '25 |
Option Exercise |
0.00 |
406 |
0 |
21,426 |
0.38%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):